Endothelin receptor antagonist
From Wikipedia, the free encyclopediaJump to navigation Jump to search
Three main kinds of ERAs exist:
- selective ETA receptor antagonists (sitaxentan, ambrisentan, atrasentan, BQ-123, zibotentan), which affect endothelin A receptors.
- dual antagonists (bosentan, macitentan, tezosentan), which affect both endothelin A and B receptors.
- selective ETB receptor antagonists (BQ-788 and A192621) which affect endothelin B receptors are used in research but have not yet reached the clinical trial stage.
Edonentan is an endothelin receptor antagonist drug.
|Endothelin receptor antagonists|
|This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.|